CoChat
Cited by 53

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Potential neurotoxic activity of diverse molecules released by microglia

Lindhout, Ivan A., Murray, Taryn E., Richards, Christy M., Klegeris, Andis · 2021 · Neurochemistry International

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuint.2021.105117

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 196

  1. Adelita, 2017, Proteolytic processed form of CXCL12 abolishes migration and induces apoptosis in neural stem cells in vitro, Stem Cell Res., 22, 61, 10.1016/j.scr.2017.05.013 · DOI
  2. Aebischer, 2013, Death receptors in the selective degeneration of motoneurons in amyotrophic lateral sclerosis, J. Neurodegener. Dis., 1
  3. Aihara, 2000, Interaction between neurone and microglia mediated by platelet-activating factor, Gene Cell., 5, 397, 10.1046/j.1365-2443.2000.00333.x · DOI
  4. Andersson, 2018, Extracellular HMGB1 as a therapeutic target in inflammatory diseases, Expert Opin. Ther. Targets, 22, 263, 10.1080/14728222.2018.1439924 · DOI · Paper page
  5. Appel, 1995, Expression of interleukin-3 and tumor necrosis factor-β mRNAs in cultured microglia, J. Neuroimmunol., 60, 83, 10.1016/0165-5728(95)00057-9 · DOI
  6. Arif, 2007, Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions, Neurosci. Res., 57, 248, 10.1016/j.neures.2006.10.021 · DOI
  7. Asahina, 2001, Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain, Clin. Neuropathol., 20, 60
  8. Asavarut, 2013, The role of HMGB1 in inflammation-mediated organ injury, Acta Anaesthesiol. Taiwanica, 51, 28, 10.1016/j.aat.2013.03.007 · DOI
  9. Bai, 2014, TLR2 signaling directs NO-dependent MMP-9 induction in mouse microglia, Neurosci. Lett., 571, 5, 10.1016/j.neulet.2014.04.025 · DOI
  10. Banisadr, 2003, Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons, Eur. J. Neurosci., 18, 1593, 10.1046/j.1460-9568.2003.02893.x · DOI
  11. Barger, 1995, Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation, Proc. Natl. Acad. Sci. U.S.A., 92, 9328, 10.1073/pnas.92.20.9328 · DOI · Paper page
  12. Bate, 2006, Platelet-activating factor antagonists protect amyloid-β damaged neurons from microglia-mediated death, Neuropharmacology, 51, 173, 10.1016/j.neuropharm.2006.02.015 · DOI
  13. Bauvois, 2012, New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression, Biochim. Biophys. Acta Rev. Canc, 29, 10.1016/j.bbcan.2011.10.001 · DOI · Paper page
  14. Bazan, 2005, Lipid signaling in neural plasticity, brain repair, and neuroprotection, Mol. Neurobiol., 32, 89, 10.1385/MN:32:1:089 · DOI · Paper page
  15. Bazan, 1997, Bioactive lipids in excitatory neurotransmission and neuronal plasticity, Neurochem. Int., 30, 225, 10.1016/S0197-0186(96)00020-4 · DOI
  16. Bellemère, 2004, Localization of the mRNA encoding prolyl endopeptidase in the rat brain and pituitary, J. Comp. Neurol., 471, 128, 10.1002/cne.20019 · DOI
  17. Bellizzi, 2016, Platelet-activating factor receptors mediate excitatory postsynaptic hippocampal injury in experimental autoimmune encephalomyelitis, J. Neurosci., 36, 1336, 10.1523/JNEUROSCI.1171-15.2016 · DOI · Paper page
  18. Bellizzi, 2005, Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor, J. Clin. Invest., 115, 3185, 10.1172/JCI25444 · DOI
  19. Bernabeu-Zornoza, 2019, Physiological and pathological effects of amyloid-β species in neural stem cell biology, Neural Regen. Res., 14, 2035, 10.4103/1673-5374.262571 · DOI
  20. Björklund, 2005, Gelatinase-mediated migration and invasion of cancer cells, Biochim. Biophys. Acta Rev. Canc, 1755, 37, 10.1016/j.bbcan.2005.03.001 · DOI · Paper page
  21. Block, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat. Rev. Neurosci., 8, 57, 10.1038/nrn2038 · DOI · Paper page
  22. Bortolotti, 2019, HHV-6A infection induces amyloid-beta expression and activation of microglial cells, Alzheimer's Res. Ther., 11, 104, 10.1186/s13195-019-0552-6 · DOI
  23. Brown, 2015, How microglia kill neurons, Brain Res., 1628, 288, 10.1016/j.brainres.2015.08.031 · DOI · Paper page
  24. Busillo, 2007, Regulation of CXCR4 signaling, Biochim. Biophys. Acta, 1768, 952, 10.1016/j.bbamem.2006.11.002 · DOI · Paper page
  25. Calmon-Hamaty, 2011, Lymphotoxin α revisited: general features and implications in rheumatoid arthritis, Arthritis Res. Ther., 13, 232, 10.1186/ar3376 · doi:10.1186/ar3376
  26. Calvo-Rodriguez, 2016, Aging enables Ca2+ overload and apoptosis induced by amyloid-β oligomers in rat hippocampal neurons: neuroprotection by non-steroidal anti-inflammatory drugs and r-flurbiprofen in aging neurons, J. Alzheimer Dis., 54, 207, 10.3233/JAD-151189 · DOI
  27. Cantres-Rosario, 2015, Interacting partners of macrophage-secreted cathepsin B contribute to HIV-induced neuronal apoptosis, AIDS, 29, 2081, 10.1097/QAD.0000000000000823 · DOI
  28. Cantres-Rosario, 2019, HIV infection induces extracellular cathepsin B uptake and damage to neurons, Sci. Rep., 9, 1, 10.1038/s41598-019-44463-1 · DOI
  29. Cheeran, 2003, CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10, J. Virol., 77, 4502, 10.1128/JVI.77.8.4502-4515.2003 · DOI
  30. Cheng, 2017, The role of SDF-1/CXCR4/CXCR7 in neuronal regeneration after cerebral ischemia, Front. Neurosci., 11, 590, 10.3389/fnins.2017.00590 · DOI
  31. Cho, 2019, A modular analysis of microglia gene expression, insights into the aged phenotype, BMC Genom., 20, 164, 10.1186/s12864-019-5549-9 · DOI
  32. Chung, 1999, Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid β-peptide by microglial cells, J. Biol. Chem., 274, 32301, 10.1074/jbc.274.45.32301 · DOI · Paper page
  33. Clausen, 2020, Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke, Acta Neuropathol. Commun., 8, 81, 10.1186/s40478-020-00957-y · DOI
  34. Coleman, 2017, Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7, J. Neuroinflammation, 14, 22, 10.1186/s12974-017-0799-4 · DOI · Paper page
  35. Colton, 2009, Heterogeneity of microglial activation in the innate immune response in the brain, J. Neuroimmune Pharmacol., 4, 399, 10.1007/s11481-009-9164-4 · DOI · Paper page
  36. Constantinescu, 2011, Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS), Br. J. Pharmacol., 164, 1079, 10.1111/j.1476-5381.2011.01302.x · DOI · Paper page
  37. Czeh, 2011, The yin and yang of microglia, Dev. Neurosci., 33, 199, 10.1159/000328989 · DOI · Paper page
  38. Das, 2015, Multifaceted innate immune responses engaged by astrocytes, microglia and resident dendritic cells against Chikungunya neuroinfection, J. Gen. Virol., 96, 294, 10.1099/vir.0.071175-0 · DOI
  39. De Haas, 2007, Neuronal chemokines: versatile messengers in central nervous system cell interaction, Mol. Neurobiol., 36, 137, 10.1007/s12035-007-0036-8 · DOI · Paper page
  40. Delgado, 2003, Inhibition of interferon (IFN) γ-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide. Inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression, J. Biol. Chem., 278, 27620, 10.1074/jbc.M303199200 · DOI
  41. Denoyer, 2012, CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension, PloS One, 7, 10.1371/journal.pone.0037873 · doi:10.1371/journal.pone.0037873
  42. Derk, 2018, The receptor for advanced glycation endproducts (RAGE) and mediation of inflammatory neurodegeneration, J. Alzheimer Dis. Park., 8, 421
  43. Di Daniel, 2009, Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity, Mol. Cell. Neurosci., 41, 373, 10.1016/j.mcn.2009.03.003 · DOI
  44. Diociaiuti, 2014, Native metastable prefibrillar oligomers are the most neurotoxic species among amyloid aggregates, Biochim. Biophys. Acta (BBA) - Mol. Basis Dis., 1622, 10.1016/j.bbadis.2014.06.006 · DOI
  45. Domingues, 2017, Impact of cytokines and chemokines on Alzheimer's disease neuropathological hallmarks, Curr. Alzheimer Res., 14, 870, 10.2174/1567205014666170317113606 · DOI · Paper page
  46. Dopp, 1997, Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia, J. Neuroimmunol., 75, 104, 10.1016/S0165-5728(97)00009-X · DOI · Paper page
  47. Duan, 2008, Decreased fractalkine and increased IP-10 expression in aged brain of APPswe transgenic mice, Neurochem. Res., 33, 1085, 10.1007/s11064-007-9554-z · DOI
  48. Dubbelaar, 2018, The kaleidoscope of microglial phenotypes, Front. Immunol., 9, 1753, 10.3389/fimmu.2018.01753 · DOI · Paper page
  49. Dukhinova, 2018, Platelets mediate protective neuroinflammation and promote neuronal plasticity at the site of neuronal injury, Brain Behav. Immun., 74, 7, 10.1016/j.bbi.2018.09.009 · DOI
  50. Etemadi, 2013, Lymphotoxin α induces apoptosis, necroptosis and inflammatory signals with the same potency as tumour necrosis factor, FEBS J., 280, 5283, 10.1111/febs.12419 · DOI
  51. Fainardi, 2009, Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis, Mult. Scler. J., 15, 547, 10.1177/1352458509102372 · DOI
  52. Frackowiak, 1992, Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils, Acta Neuropathol., 84, 225, 10.1007/BF00227813 · DOI · Paper page
  53. Fricker, 2018, Neuronal cell death, Physiol. Rev., 98, 813, 10.1152/physrev.00011.2017 · DOI · Paper page
  54. Fridman, 2003, Cell surface association of matrix metalloproteinase-9 (gelatinase B), Canc. Metastasis Rev., 22, 153, 10.1023/A:1023091214123 · DOI
  55. Gan, 2004, Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach, J. Biol. Chem., 279, 5565, 10.1074/jbc.M306183200 · DOI
  56. Gelbard, 1994, Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin, J. Virol., 68, 4628, 10.1128/jvi.68.7.4628-4635.1994 · DOI · Paper page
  57. Genis, 1992, Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease, J. Exp. Med., 176, 1703, 10.1084/jem.176.6.1703 · DOI · Paper page
  58. Ginhoux, 2010, Fate mapping analysis reveals that adult microglia derive from primitive macrophages, Science, 330, 841, 10.1126/science.1194637 · DOI · Paper page
  59. Gomez Perdiguero, 2015, Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors, Nature, 518, 547, 10.1038/nature13989 · DOI · Paper page
  60. Goossens, 1995, The purification, characterization and analysis of primary and secondary-structure of prolyl oligopeptidase from human lymphocytes. Evidence that the enzyme belongs to the alpha/beta hydrolase fold family, Eur. J. Biochem., 233, 432, 10.1111/j.1432-1033.1995.432_2.x · DOI
  61. Gorgulho, 2019, Johnny on the spot-chronic inflammation is driven by HMGB1, Front. Immunol., 10, 1561, 10.3389/fimmu.2019.01561 · DOI
  62. Gotsch, 2007, CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia?, J. Matern. Neonatal Med., 20, 777, 10.1080/14767050701483298 · DOI
  63. Gottschall, 1995, Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture, J. Neurosci. Res., 42, 335, 10.1002/jnr.490420307 · DOI
  64. Gray, 1984, Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity, Nature, 312, 721, 10.1038/312721a0 · DOI · Paper page
  65. Gu, 2005, A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia, J. Neurosci., 25, 6401, 10.1523/JNEUROSCI.1563-05.2005 · DOI · Paper page
  66. Haass, 1991, Processing of β-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion, J. Neurosci., 11, 3793, 10.1523/JNEUROSCI.11-12-03783.1991 · DOI · Paper page
  67. Hanisch, 2013, Proteins in microglial activation - inputs and outputs by subsets, Curr. Protein Pept. Sci., 14, 3, 10.2174/1389203711314010003 · DOI
  68. Hannula, 2013, Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases, Neuroscience, 242, 140, 10.1016/j.neuroscience.2013.03.049 · DOI
  69. Harry, 2000, Age-dependent cytokine responses: trimethyltin hippocampal injury in wild-type, APOE knockout, and APOE4 mice, Brain Behav. Immun., 14, 288, 10.1006/brbi.2000.0606 · DOI
  70. Helmy, 2011, The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production, J. Cerebr. Blood Flow Metabol., 31, 658, 10.1038/jcbfm.2010.142 · DOI · Paper page
  71. Hirashima, 1994, Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage, J. Neurosurg., 80, 31, 10.3171/jns.1994.80.1.0031 · DOI
  72. Hook, 2015, Cathepsin B is a new drug target for traumatic brain injury therapeutics: evidence for E64d as a promising lead drug candidate, Front. Neurol., 6, 178, 10.3389/fneur.2015.00178 · DOI
  73. Hua, 2000, Distinct patterns of stimulus‐inducible chemokine mRNA accumulation in human fetal astrocytes and microglia, Glia, 30, 74, 10.1002/(SICI)1098-1136(200003)30:1<74::AID-GLIA8>3.0.CO;2-C · DOI
  74. Huttunen, 2000, Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation, J. Biol. Chem., 275, 40096, 10.1074/jbc.M006993200 · DOI · Paper page
  75. Inoue, 2016, An interferon-β-resistant and NLRP3 inflammasome-independent subtype of EAE with neuronal damage, Nat. Neurosci., 19, 1599, 10.1038/nn.4421 · DOI
  76. Jaako, 2016, Prolyl endopeptidase is involved in the degradation of neural cell adhesion molecules in vitro, J. Cell Sci., 129, 3792, 10.1242/jcs.181891 · doi:10.1242/jcs.181891
  77. Jana, 2009, Induction of lymphotoxin-alpha by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70, Immunology, 127, 312, 10.1111/j.1365-2567.2008.02985.x · DOI
  78. Jaranowska, 1995, Platelet-activating factor production by human fetal microglia. Effect of lipopolysaccharides and tumor necrosis factor-α, Mol. Chem. Neuropathol., 24, 95, 10.1007/BF02962136 · DOI
  79. Jeon, 2010, Analysis of glial secretome: the long pentraxin PTX3 modulates phagocytic activity of microglia, J. Neuroimmunol., 229, 63, 10.1016/j.jneuroim.2010.07.001 · DOI
  80. Jin, 2008, Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization, Bone Marrow Transplant., 42, 581, 10.1038/bmt.2008.222 · DOI
  81. Joshi, 2014, Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles, Cell Death Differ., 21, 582, 10.1038/cdd.2013.180 · DOI · Paper page
  82. Katsube, 1999, ONO-1603, a potential antidementia drug, delays age-induced apoptosis and suppresses overexpression of glyceraldehyde-3-phosphate dehydrogenase in cultured central nervous system neurons, J. Pharmacol. Exp. Therapeut., 288, 6, 10.1016/S0022-3565(24)37917-0 · DOI
  83. Kauppinen, 2005, Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death, J. Immunol., 174, 2288, 10.4049/jimmunol.174.4.2288 · DOI · Paper page
  84. Kaur, 2009, Expression of syndecan-2 in the amoeboid microglial cells and its involvement in inflammation in the hypoxic developing brain, Glia, 57, 336, 10.1002/glia.20764 · DOI
  85. Kawai, 2001, Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes, J. Immunol., 167, 5887, 10.4049/jimmunol.167.10.5887 · DOI · Paper page
  86. Kendall, 2011, TNF gene cluster deletion abolishes lipopolysaccharide-mediated sensitization of the neonatal brain to hypoxic ischemic insult, Lab. Invest., 91, 328, 10.1038/labinvest.2010.192 · DOI
  87. Keren-Shaul, 2017, A unique microglia type associated with restricting development of Alzheimer's disease, Cell, 169, 1276, 10.1016/j.cell.2017.05.018 · DOI · Paper page
  88. Kielian, 2006, Toll-like receptors in central nervous system glial inflammation and homeostasis, J. Neurosci. Res., 83, 711, 10.1002/jnr.20767 · DOI · Paper page
  89. Kihara, 2008, Platelet-activating factor production in the spinal cord of experimental allergic encephalomyelitis mice via the group IVA cytosolic phospholipase A2-lyso-PAFAT axis, J. Immunol., 181, 5008, 10.4049/jimmunol.181.7.5008 · DOI
  90. Kim, 2013, Platelet-activating factor receptor knockout mice are protected from MPTP-induced dopaminergic degeneration, Neurochem. Int., 63, 121, 10.1016/j.neuint.2013.05.010 · DOI
  91. Kim, 2007, Neurotoxicity of microglial cathepsin D revealed by secretome analysis, J. Neurochem., 103, 2640, 10.1111/j.1471-4159.2007.04995.x · DOI
  92. Kim, 2011, Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway, Neurotox. Res., 20, 159, 10.1007/s12640-010-9231-x · DOI
  93. Kingham, 2001, Microglial secreted cathepsin B induces neuronal apoptosis, J. Neurochem., 76, 1475, 10.1046/j.1471-4159.2001.00146.x · DOI · Paper page
  94. Klegeris, 2008, Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity, Glia, 56, 675, 10.1002/glia.20645 · DOI
  95. Kolb, 1968, Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin, Proc. Natl. Acad. Sci. U.S.A., 61, 1250, 10.1073/pnas.61.4.1250 · DOI · Paper page
  96. Könnecke, 2013, The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas, Clin. Dev. Immunol., 914104
  97. Koper, 2018, CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration, Adv. Clin. Exp. Med., 27, 849, 10.17219/acem/68846 · DOI · Paper page
  98. Korniejewska, 2011, Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes, Immunology, 132, 503, 10.1111/j.1365-2567.2010.03384.x · DOI
  99. Kuo, 2018, The role of CXCR3 and its chemokine ligands in skin disease and cancer, Front. Med., 5, 271, 10.3389/fmed.2018.00271 · DOI · Paper page
  100. Laitinen, 2001, Brain prolyl oligopeptidase activity is associated with neuronal damage rather than β-amyloid accumulation, Neuroreport, 12, 3309, 10.1097/00001756-200110290-00032 · DOI
  101. Liaudet-Coopman, 2006, Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis, Canc. Lett., 237, 167, 10.1016/j.canlet.2005.06.007 · DOI · Paper page
  102. Lim, 2011, Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer's disease, J. Alzheimer Dis., 26, 779, 10.3233/JAD-2011-101974 · DOI
  103. Lipton, 1994, AIDS-related dementia and calcium homeostasis, Ann. N. Y. Acad. Sci., 747, 205, 10.1111/j.1749-6632.1994.tb44411.x · DOI
  104. Lipton, 1994, Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide, Adv. Neuroimmunol., 4, 181, 10.1016/S0960-5428(06)80255-X · DOI
  105. Liu, 2014, Neuroinflammation in Alzheimer’s disease: chemokines produced by astrocytes and chemokine receptors, Int. J. Clin. Exp. Pathol., 7, 8342
  106. Liu, 2008, Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies, J. Proteome Res., 7, 2033, 10.1021/pr7007779 · DOI
  107. Liuzzi, 2004, Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment, Mult. Scler. J., 10, 290, 10.1191/1352458504ms1016oa · DOI
  108. Lorenzl, 2003, Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease, Neurochem. Int., 43, 191, 10.1016/S0197-0186(03)00004-4 · DOI · Paper page
  109. Lowry, 2018, Emerging roles of microglial cathepsins in neurodegenerative disease, Brain Res. Bull., 139, 144, 10.1016/j.brainresbull.2018.02.014 · DOI
  110. Luo, 2010, Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated apoptotic pathway, J. Neurosci. Res., 88, 2847, 10.1002/jnr.22453 · DOI
  111. Magna, 2014, The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases, Mol. Med., 20, 138, 10.2119/molmed.2013.00164 · DOI · Paper page
  112. Mahiuddin, 2003, Dose-dependent effect of MK-801 on the levels of neuropeptides processing enzymes in rat brain regions, Neurosci. Res., 47, 177, 10.1016/S0168-0102(03)00197-4 · doi:10.1016/s0168-0102(03)00197-4
  113. Männistö, 2017, Mechanism of action of prolyl oligopeptidase (PREP) in degenerative brain diseases: has peptidase activity only a modulatory role on the interactions of PREP with proteins?, Front. Aging Neurosci., 9, 27, 10.3389/fnagi.2017.00027 · doi:10.3389/fnagi.2017.00027
  114. Mantle, 1996, Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease, Clin. Chim. Acta, 249, 129, 10.1016/0009-8981(96)06282-1 · DOI
  115. Martinez, 2006, Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression, J. Immunol., 177, 7303, 10.4049/jimmunol.177.10.7303 · DOI · Paper page
  116. Matsuda, 2013, Prolyl oligopeptidase is a glyceraldehyde-3-phosphate dehydrogenase-binding protein that regulates genotoxic stress-induced cell death, Int. J. Biochem. Cell Biol., 45, 850, 10.1016/j.biocel.2013.01.009 · doi:10.1016/j.biocel.2013.01.009
  117. Matusevicius, 1996, Multiple sclerosis: the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells, J. Neuroimmunol., 66, 115, 10.1016/0165-5728(96)00032-X · DOI
  118. Medvedev, 1996, Distinct roles of the two tumor necrosis factor (TNF) receptors in modulating TNF and lymphotoxin alpha effects, J. Biol. Chem., 271, 9778, 10.1074/jbc.271.16.9778 · DOI
  119. Minarowska, 2007, Regulatory role of cathepsin D in apoptosis, Folia Histochem. Cytobiol., 45, 159
  120. Mithal, 2012, CXCL12 signaling in the development of the nervous system, J. Neuroimmune Pharmacol., 7, 820, 10.1007/s11481-011-9336-x · DOI
  121. Mori, 1996, Predominant expression of platelet-activating factor receptor in the rat brain microglia, J. Neurosci., 16, 3590, 10.1523/JNEUROSCI.16-11-03590.1996 · DOI
  122. Mueller-Steiner, 2006, Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease, Neuron, 51, 703, 10.1016/j.neuron.2006.07.027 · DOI · Paper page
  123. Muhammad, 2008, The HMGB1 receptor RAGE mediates ischemic brain damage, J. Neurosci., 28, 12023, 10.1523/JNEUROSCI.2435-08.2008 · DOI · Paper page
  124. Müller, 2010, The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity – a tale of conflict and conundrum, Neuropathol. Appl. Neurobiol., 36, 368, 10.1111/j.1365-2990.2010.01089.x · DOI · Paper page
  125. Murakami, 2011, Subarachnoid hemorrhage induces gliosis and increased expression of the pro-inflammatory cytokine high mobility group box 1 protein, Transl. Stroke Res., 2, 72, 10.1007/s12975-010-0052-2 · DOI
  126. Myöhänen, 2009, Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity, J. Histochem. Cytochem., 57, 831, 10.1369/jhc.2009.953711 · DOI
  127. Myöhänen, 2012, A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease, Br. J. Pharmacol., 166, 1097, 10.1111/j.1476-5381.2012.01846.x · DOI
  128. Nakanishi, 2020, Microglial cathepsin B as a key driver of inflammatory brain diseases and brain aging, Neural Regen. Res., 15, 25, 10.4103/1673-5374.264444 · DOI
  129. Natunen, 2019, Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target, Basic Clin. Pharmacol. Toxicol., 124, 40, 10.1111/bcpt.13094 · DOI
  130. Ni, 2015, The critical role of proteolytic relay through cathepsins B and E in the phenotypic change of microglia/macrophage, J. Neurosci., 35, 12488, 10.1523/JNEUROSCI.1599-15.2015 · DOI
  131. Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 · DOI · Paper page
  132. Pennica, 1984, Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin, Nature, 312, 724, 10.1038/312724a0 · DOI · Paper page
  133. Penttinen, 2011, Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research, CNS Neurol. Disord. - Drug Targets, 10, 340, 10.2174/187152711794653742 · doi:10.2174/187152711794653742
  134. Plant, 2007, Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein, J. Neurosci., 27, 7429, 10.1523/JNEUROSCI.1307-07.2007 · DOI · Paper page
  135. Prescott, 2000, Platelet-activating factor and related lipid mediators, Annu. Rev. Biochem., 69, 419, 10.1146/annurev.biochem.69.1.419 · DOI · Paper page
  136. Probert, 2000, TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease, Brain, 123, 10.1093/brain/123.10.2005 · DOI · Paper page
  137. Pujol, 2005, The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons, J. Cell Sci., 118, 1071, 10.1242/jcs.01694 · DOI
  138. Puttonen, 2006, A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine, Toxicol. Vitro, 20, 1446, 10.1016/j.tiv.2006.07.001 · DOI
  139. Ren, 1998, Lipopolysaccharide-induced expression of IP-10 mRNA in rat brain and in cultured rat astrocytes and microglia, Mol. Brain Res., 59, 256, 10.1016/S0169-328X(98)00170-3 · DOI
  140. Roach, 2001, Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection, J. Exp. Med., 193, 239, 10.1084/jem.193.2.239 · DOI · Paper page
  141. Rock, 2005, Transcriptional response of human microglial cells to interferon-γ, Gene Immun., 6, 712, 10.1038/sj.gene.6364246 · DOI
  142. Rossner, 2005, Brain prolyl endopeptidase expression in aging, APP transgenic mice and Alzheimer’s disease, Neurochem. Res., 30, 695, 10.1007/s11064-005-6863-y · DOI
  143. Rumbaugh, 2006, Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism, Faseb. J., 20, 1736, 10.1096/fj.05-5619fje · DOI
  144. Ryan, 1995, Microglial cathepsin B: an immunological examination of cellular and secreted species, J. Neurochem., 65, 1035, 10.1046/j.1471-4159.1995.65031035.x · DOI
  145. Ryan, 2007, Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid, J. Neurochem., 103, 88, 10.1111/j.1471-4159.2007.04740.x · DOI
  146. Santoro, 2016, In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin, Neurobiol. Dis., 91, 59, 10.1016/j.nbd.2016.02.018 · DOI
  147. Schetters, 2018, Neuroinflammation: microglia and T cells get ready to tango, Front. Immunol., 8, 1905, 10.3389/fimmu.2017.01905 · DOI · Paper page
  148. Schulz, 2005, Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion, J. Neurochem., 94, 970, 10.1111/j.1471-4159.2005.03237.x · doi:10.1111/j.1471-4159.2005.03237.x
  149. Sedger, 2014, TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future, Cytokine Growth Factor Rev., 25, 453, 10.1016/j.cytogfr.2014.07.016 · DOI · Paper page
  150. Selmaj, 1991, Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions, J. Clin. Invest., 87, 949, 10.1172/JCI115102 · DOI · Paper page
  151. Shen, 2006, MAP kinase regulation of IP10/CXCL10 chemokine gene expression in microglial cells, Brain Res., 1086, 9, 10.1016/j.brainres.2006.02.116 · DOI
  152. Shi, 2018, DNA binding protein HMGB1 secreted by activated microglia promotes the apoptosis of hippocampal neurons in diabetes complicated with OSA, Brain Behav. Immun., 73, 482, 10.1016/j.bbi.2018.06.012 · DOI
  153. Shin, 2014, Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain, Neurosci. Lett., 558, 159, 10.1016/j.neulet.2013.11.006 · DOI
  154. Shishido, 1996, ZTTA, a postproline cleaving enzyme inhibitor, improves cerebral ischemia-induced deficits in a three-panel runway task in rats, Pharmacol. Biochem. Behav., 55, 333, 10.1016/S0091-3057(96)00102-5 · doi:10.1016/s0091-3057(96)00102-5
  155. Shishido, 1999, Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats, Eur. J. Pharmacol., 372, 135, 10.1016/S0014-2999(99)00185-5 · DOI
  156. Sierra, 2014, Surveillance, phagocytosis, and inflammation: how never-resting microglia influence adult hippocampal neurogenesis, Neural Plast., 610343
  157. Skinner, 2019, Chemokine CXCL10 and coronavirus-induced neurologic disease, Viral Immunol., 32, 25, 10.1089/vim.2018.0073 · DOI
  158. Spies, 1986, Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex, Proc. Natl. Acad. Sci. U.S.A., 83, 8699, 10.1073/pnas.83.22.8699 · DOI · Paper page
  159. Stomrud, 2010, Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease, Alzheimer's Res. Ther., 2, 20, 10.1186/alzrt44 · DOI
  160. Sui, 2004, Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis, Am. J. Pathol., 164, 1557, 10.1016/S0002-9440(10)63714-5 · DOI
  161. Sui, 2006, CXCL10-induced cell death in neurons: role of calcium dysregulation, Eur. J. Neurosci., 23, 957, 10.1111/j.1460-9568.2006.04631.x · DOI · Paper page
  162. Takeuchi, 2010, Neurotoxicity by microglia: mechanisms and potential therapeutic strategy, Clin. Exp. Neuroimmunol., 1, 12, 10.1111/j.1759-1961.2009.00001.x · DOI
  163. Tang, 2016, Differential roles of M1 and M2 microglia in neurodegenerative diseases, Mol. Neurobiol., 53, 1181, 10.1007/s12035-014-9070-5 · DOI · Paper page
  164. Tanokashira, 2017, The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model, Mol. Brain, 10, 1, 10.1186/s13041-016-0284-5 · DOI
  165. Tenorio-Laranga, 2015, The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients, J. Neuroinflammation, 12, 183, 10.1186/s12974-015-0404-7 · doi:10.1186/s12974-015-0404-7
  166. Terada, 2010, Involvement of cathepsin B in the processing and secretion of interleukin-1β in chromogranin A-stimulated microglia, Glia, 58, 114, 10.1002/glia.20906 · DOI
  167. Terni, 2015, Abnormal expression and distribution of MMP2 at initial stages of Alzheimer's disease-related pathology, J. Alzheimer Dis., 46, 461, 10.3233/JAD-142460 · DOI
  168. Thelen, 2008, CXCR7, CXCR4 and CXCL12: an eccentric trio?, J. Neuroimmunol., 198, 9, 10.1016/j.jneuroim.2008.04.020 · DOI · Paper page
  169. Tomimoto, 1996, Glial expression of cytokines in the brains of cerebrovascular disease patients, Acta Neuropathol., 92, 281, 10.1007/s004010050519 · DOI
  170. Tong, 1995, Stimulation of group II phospholipase A2 mRNA expression and release in an immortalized astrocyte cell line (DITNC) by LPS, TNF alpha, and IL-I beta. Interactive effects, Mol. Chem. Neuropathol., 25, 1, 10.1007/BF02815083 · DOI
  171. Trallero, 2019, The role of prolyl oligopeptidase in microtubule-associated processes and cognitive impairment, Int. J. Brain Disord. Treat., 5, 5
  172. Tsakiri, 2008, Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones, Mol. Cell. Neurosci., 38, 259, 10.1016/j.mcn.2008.02.015 · DOI
  173. Valenzuela-Fernández, 2002, Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4, J. Biol. Chem., 277, 15677, 10.1074/jbc.M111388200 · DOI · Paper page
  174. Van Marle, 2004, Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10, Virology, 329, 302, 10.1016/j.virol.2004.08.024 · DOI · Paper page
  175. Vanguri, 1994, IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-A alpha in astrocytes and microglia, J. Immunol., 152, 1411, 10.4049/jimmunol.152.3.1411 · DOI
  176. Vergote, 2006, Proteolytic processing of SDF-1 alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration, Proc. Natl. Acad. Sci. U.S.A., 103, 10.1073/pnas.0604678103 · DOI
  177. Vincent, 2007, Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress, Endocrinology, 148, 548, 10.1210/en.2006-0073 · DOI · Paper page
  178. Walter, 2009, Role of microglia in neuronal degeneration and regeneration, Semin. Immunopathol., 31, 513, 10.1007/s00281-009-0180-5 · DOI
  179. Wegiel, 1990, The complex of microglial cells and amyloid star in three-dimensional reconstruction, Acta Neuropathol., 81, 116, 10.1007/BF00334499 · DOI · Paper page
  180. Wen, 2006, Activated microglial supernatant induced motor neuron cytotoxicity is associated with upregulation of the TNFR1 receptor, Neurosci. Res., 55, 87, 10.1016/j.neures.2006.02.004 · DOI
  181. Windelborn, 2008, Lysosomal release of cathepsins causes ischemic damage in the rat hippocampal slice and depends on NMDA-mediated calcium influx, arachidonic acid metabolism, and free radical production, J. Neurochem., 106, 56, 10.1111/j.1471-4159.2008.05349.x · DOI
  182. Wirths, 2010, Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease, Neurobiol. Aging, 31, 747, 10.1016/j.neurobiolaging.2008.06.011 · DOI
  183. Wirths, 2019, Emerging roles of N- and C-terminally truncated Aβ species in Alzheimer's disease, Expert Opin. Ther. Targets, 23, 991, 10.1080/14728222.2019.1702972 · DOI · Paper page
  184. Wisniewski, 1990, Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie, Am. J. Med. Genet., 7, 287
  185. Wisniewski, 1989, Ultrastructural studies of the cells forming amyloid fibers in classical plaques, J. Neurol. Sci., 16, 535
  186. Woo, 2017, Quantitative proteomics reveals temporal proteomic changes in signaling pathways during BV2 mouse microglial cell activation, J. Proteome Res., 16, 3419, 10.1021/acs.jproteome.7b00445 · DOI
  187. Xing, 2016, Upregulation of microRNA-206 enhances lipopolysaccharide-induced inflammation and release of amyloid-β by targeting insulin-like growth factor 1 in microglia, Mol. Med. Rep., 14, 1357, 10.3892/mmr.2016.5369 · DOI
  188. Xu, 2019, Microglia activated by excess cortisol induce HMGB1 acetylation and neuroinflammation in the hippocampal DG region of mice following cold exposure, Biomolecules, 9, 426, 10.3390/biom9090426 · DOI
  189. Yang, 2020, Targeting inflammation driven by HMGB1, Front. Immunol., 11, 484, 10.3389/fimmu.2020.00484 · DOI · Paper page
  190. Yang, 2015, Mitogen-activated protein kinase signaling pathways promote low-density lipoprotein receptor-related protein 1-mediated internalization of beta-amyloid protein in primary cortical neurons, Int. J. Biochem. Cell Biol., 64, 252, 10.1016/j.biocel.2015.04.013 · DOI
  191. Yelamanchili, 2011, Upregulation of cathepsin D in the caudate nucleus of primates with experimental parkinsonism, Mol. Neurodegener., 6, 52, 10.1186/1750-1326-6-52 · DOI
  192. Yin, 2017, Loss of PAFR prevents neuroinflammation and brain dysfunction after traumatic brain injury, Sci. Rep., 7, 1
  193. Zenón, 2015, HIV-infected microglia mediate cathepsin B induced neurotoxicity, J. Neurovirol., 21, 544, 10.1007/s13365-015-0358-7 · DOI
  194. Zhang, 2003, HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration, Nat. Neurosci., 6, 1064, 10.1038/nn1127 · DOI · Paper page
  195. Zhang, 2018, TNF-alpha and TNF-R1 regulate bupivacaine-induced apoptosis in spinal cord dorsal root ganglion neuron, Eur. J. Pharmacol., 833, 63, 10.1016/j.ejphar.2018.05.034 · DOI
  196. Zhu, 2009, CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy, Faseb. J., 23, 2928, 10.1096/fj.08-128819 · DOI

Cited by

See all 53

Metadata

Authors
Lindhout, I. A., Murray, T. E., Richards, C. M., & Klegeris, A.
Venue
Neurochemistry International
Publisher
Elsevier BV
Published
2021-09
Volume
148
Pages
105117
ISSN
0197-0186
Cited by
53
References
44
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.